β-adrenoceptor regulates miRNA expression in rat heart

Area of Science:

• Cardiovascular Biology
• Molecular Biology
• Gene Regulation

Background:

• MicroRNAs (miRNAs) are key post-transcriptional regulators of gene expression, implicated in numerous physiological and pathological processes.
• The beta-adrenergic signaling pathway is crucial for regulating cardiac function.
• Understanding miRNA dynamics in response to beta-adrenergic stimulation or blockade is vital for cardiac research.

Purpose of the Study:

• To investigate the impact of beta-adrenoceptor activation and inhibition on miRNA expression profiles in the rat heart.
• To explore the functional implications of these miRNA alterations within the context of beta-adrenergic signaling.

Main Methods:

• Hemodynamic parameters were monitored in Wistar rats following treatment with isoproterenol (ISO) or propranolol (PRO).
• miRNA expression profiling was performed using miRNA Microarray analysis.
• Quantitative real-time reverse transcription PCR (qRT-PCR) was employed for validation of specific miRNA expression changes.

Main Results:

• Both ISO (activator) and PRO (inhibitor) treatments induced distinct miRNA expression profiles, with significant numbers of upregulated and downregulated miRNAs observed in each group.
• Eleven cardiac-abundant miRNAs and eleven miRNAs with opposing expression patterns between ISO and PRO groups were identified.
• Specific miRNAs known to influence cardiomyocyte hypertrophy, such as miR-1, miR-21, miR-27b (anti-hypertrophic), and miR-22, miR-24, miR-199a, miR-212, miR-214 (pro-hypertrophic), showed altered expression, with notable changes in miR-30c and miR-212 in the PRO group.

Conclusions:

• Intervention targeting beta-adrenoceptors demonstrably alters the cardiac miRNA expression landscape.
• miRNAs are implicated as active participants in the beta-adrenergic signaling pathway.
• Cardiomyocyte hypertrophy appears to be a finely tuned process involving a balance of pro-hypertrophic and anti-hypertrophic regulatory mechanisms, with significant miRNA involvement.